U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H22O3
Molecular Weight 286.3655
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 4-HYDROXYESTRONE

SMILES

C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(O)=CC=C34)[C@@H]1CCC2=O

InChI

InChIKey=XQZVQQZZOVBNLU-QDTBLXIISA-N
InChI=1S/C18H22O3/c1-18-9-8-11-10-4-6-15(19)17(21)13(10)3-2-12(11)14(18)5-7-16(18)20/h4,6,11-12,14,19,21H,2-3,5,7-9H2,1H3/t11-,12-,14+,18+/m1/s1

HIDE SMILES / InChI

Molecular Formula C18H22O3
Molecular Weight 286.3655
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/11054642

4-Hydroxyestrone (4-OHE1) is a carcinogenic metabolite originating from 17beta-estradiol (17β-E2) hormone. 4-OHE1 was a partial estrogen agonist on cancellous bone turnover, similar to 17β-E2, is able to emit electrons from its excited singlet state. The quantum yield is nearly the same like this of 17β-E2 and decreases with increasing substrate concentration, but enhances with temperature. The 4-OHE1 transient derived from the electron ejection process is leading to the formation of a secondary metabolite by reaction with the present C2H4OH radical. This fact indicates, that depending on the life habits of a person, a variety of metabolites can be formed, also such initiating cancer.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
NRF2/long noncoding RNA ROR signaling regulates mammary stem cell expansion and protects against estrogen genotoxicity.
2014-11-07
Effects of a breast-health herbal formula supplement on estrogen metabolism in pre- and post-menopausal women not taking hormonal contraceptives or supplements: a randomized controlled trial.
2010-12-16
Redox cycling of catechol estrogens generating apurinic/apyrimidinic sites and 8-oxo-deoxyguanosine via reactive oxygen species differentiates equine and human estrogens.
2010-08-16
Comparison of estrogens and estrogen metabolites in human breast tissue and urine.
2010-08-02
Degradation of natural estrogen and identification of the metabolites produced by soil isolates of Rhodococcus sp. and Sphingomonas sp.
2010-06
The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo.
2010-05-21
Simultaneous determination of eight estrogens and their metabolites in serum using liquid chromatography with electrochemical detection.
2010-04-15
The 4-hydroxyestrone: Electron emission, formation of secondary metabolites and mechanisms of carcinogenesis.
2010-01-21
Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.
2009
Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia.
2008-11-27
Contribution of alpha2-adrenoceptors to the mitogenic effect of catecholestrogen in human breast cancer MCF-7 cells.
2008-05
Evaluation of electrospray ionization and atmospheric pressure chemical ionization for simultaneous detection of estrone and its metabolites using high-performance liquid chromatography/tandem mass spectrometry.
2007-12-01
HPLC for stress-free screening of potential prostate cancer marker catechol estrogens in urine using a diamond-electrode electrochemical and a fluorescence detector.
2007-09
Effects of a catechol-O-methyltransferase inhibitor on catechol estrogen-induced cellular transformation, chromosome aberrations and apoptosis in Syrian hamster embryo cells.
2007-04-15
Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33.
2007-03
Effects of dioxin on metabolism of estrogens in waste incinerator workers.
2007-01-12
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.
2006-11
Potential biomarker for early risk assessment of prostate cancer.
2006-10-01
In vitro short-term test evaluation of catecholestrogens genotoxicity.
2006-06-12
Analysis of fifteen estrogen metabolites using packed column supercritical fluid chromatography-mass spectrometry.
2006-03-01
Role of polymorphic human cytochrome P450 enzymes in estrone oxidation.
2006-03
Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone.
2006-01-01
Development of monoclonal antibodies to 4-hydroxyestrogen-2-N-acetylcysteine conjugates: immunoaffinity and spectroscopic studies.
2005-10
The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17beta-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16alpha-hydroxyestradiol, and 4-hydroxyestrone.
2004-10
Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation.
2004-07-02
Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types.
2004-07
Equine estrogen metabolite 4-hydroxyequilenin induces anchorage-independent growth of human mammary epithelial MCF-10A cells: differential gene expression.
2004-06-04
Estrogen receptor-independent catechol estrogen binding activity: protein binding studies in wild-type, Estrogen receptor-alpha KO, and aromatase KO mice tissues.
2004-06-01
Identification of UGT2B9*2 and UGT2B33 isolated from female rhesus monkey liver.
2004-06-01
Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview.
2004
Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract.
2003-09
Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.
2003-08
Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry.
2003-05
Endogenous estradiol metabolites stimulate the in vitro proliferation of human osteoblastic cells.
2003-04
Spectroscopic characterization of the 4-hydroxy catechol estrogen quinones-derived GSH and N-acetylated Cys conjugates.
2003-03
Estradiol metabolism and malignant disease.
2002-09-30
Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers.
2002-04
Catecholestrogen sulfation: possible role in carcinogenesis.
2002-03-29
Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases.
2001-12
The ability of four catechol estrogens of 17beta-estradiol and estrone to induce DNA adducts in Syrian hamster embryo fibroblasts.
2001-09
Selective synthesis of 4-methoxyestrogen from 4-hydroxyestrogen.
2001-08
In vitro generation of peroxynitrite by 2- and 4-hydroxyestrogens in the presence of nitric oxide.
2001-05
Evidence that a metabolite of equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro.
2001-01
Quantitative determination of 3,3'-diindolylmethane in urine of individuals receiving indole-3-carbinol.
2001
Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: studies using Syrian hamster embryo cells treated with 17beta-estradiol and eight of its metabolites.
2000-04-01
Characterization of rabbit UDP-glucuronosyltransferase UGT1A7: tertiary amine glucuronidation is catalyzed by UGT1A7 and UGT1A4.
1997-08-15
Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.
1994-09-01
cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily.
1993-07-15
Reinduction of the hypnotic effects of thiopental with NSAIDs by decreasing thiopental plasma protein binding in humans.
1993-04
Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs.
1993-01

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:35:33 GMT 2025
Edited
by admin
on Mon Mar 31 17:35:33 GMT 2025
Record UNII
3MN57C55S2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
3,4-DIHYDROXY-1,3,5(10)-ESTRATRIEN-17-ONE
Preferred Name English
4-HYDROXYESTRONE
Common Name English
ESTRA-1,3,5(10)-TRIEN-17-ONE, 3,4-DIHYDROXY-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C2181
Created by admin on Mon Mar 31 17:35:33 GMT 2025 , Edited by admin on Mon Mar 31 17:35:33 GMT 2025
Code System Code Type Description
WIKIPEDIA
4-Hydroxyestrone
Created by admin on Mon Mar 31 17:35:33 GMT 2025 , Edited by admin on Mon Mar 31 17:35:33 GMT 2025
PRIMARY
NCI_THESAURUS
C114469
Created by admin on Mon Mar 31 17:35:33 GMT 2025 , Edited by admin on Mon Mar 31 17:35:33 GMT 2025
PRIMARY
FDA UNII
3MN57C55S2
Created by admin on Mon Mar 31 17:35:33 GMT 2025 , Edited by admin on Mon Mar 31 17:35:33 GMT 2025
PRIMARY
PUBCHEM
9971251
Created by admin on Mon Mar 31 17:35:33 GMT 2025 , Edited by admin on Mon Mar 31 17:35:33 GMT 2025
PRIMARY
MESH
C026418
Created by admin on Mon Mar 31 17:35:33 GMT 2025 , Edited by admin on Mon Mar 31 17:35:33 GMT 2025
PRIMARY
CAS
3131-23-5
Created by admin on Mon Mar 31 17:35:33 GMT 2025 , Edited by admin on Mon Mar 31 17:35:33 GMT 2025
PRIMARY
EPA CompTox
DTXSID00904312
Created by admin on Mon Mar 31 17:35:33 GMT 2025 , Edited by admin on Mon Mar 31 17:35:33 GMT 2025
PRIMARY
CHEBI
87602
Created by admin on Mon Mar 31 17:35:33 GMT 2025 , Edited by admin on Mon Mar 31 17:35:33 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY